Multiple Myeloma Clinical Trials

A listing of 183 Multiple Myeloma clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.

Home

All Conditions

Multiple Myeloma

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

There are currently 183 active clinical trials seeking participants for Multiple Myeloma research studies. The states with the highest number of trials for Multiple Myeloma participants are California, New York, Ohio and Texas.

Featured Trial

Paid Clinical Studies Nationwide

Recruiting

Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.

Conditions:

Healthy

Healthy Volunteer Study

Learn More

* Compensation for time may be available

Featured Trial

Chronic Cough Research Study

Recruiting

Are you tired of living with chronic cough? Our research study is now looking to enroll people from all backgrounds to help research potential new treatment options for chronic cough.
You are under no obligation to take part and health insurance is not required. Find out more today! We’d love to hear from you!

Conditions:

Chronic Cough

Refractory or Unexplained Chronic Cough

Cough

Asthma

Sinusitis

Learn More

Featured Offer

Lose Weight with GLP-1 Medications

Recruiting

Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®.

GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.

As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.

Conditions:

Overweight

Overweight and Obesity

Obesity

Weight Loss

Morbid Obesity

Learn More

Featured Trial

Stroke Clinical Study

Recruiting

A clinical study for people that suffer with Stroke

Conditions:

Stroke

Learn More

Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource

NCT01408225

Recruiting

The investigators are researching patients with diseases of their plasma cells in order to improve their quality and length of life. The investigators have created a database of patient information, blood samples, and bone marrow tissue in order to achieve the following three goals: * Surveillance: The investigators want to track what treatments patients get or don't get, how effective they are, how they feel, what complications they suffer, how long they stay in remission, and how long they li... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

01/27/2025

Locations: Ohio State University Medical Center, Columbus, Ohio

Conditions: Plasma Cell Dyscrasias, Monoclonal Gammopathy of Undetermined Significance, AL Amyloidosis, Multiple Myeloma

Learn More ›

18F-Fluciclovine PET/CT in Multiple Myeloma

NCT06103838

Recruiting

Background: Multiple myeloma (MM) is an incurable cancer of certain blood cells. MM often returns after treatment, and most people survive only 5 to 8 years after diagnosis. To improve survival, researchers need to find ways to identify returning disease earlier. Objective: To find out if the radiotracer 18F-fluciclovine (a substance injected into the blood during imaging scans) is better at detecting MM than the one (18F-FDG) currently used for this purpose. Eligibility: Adults aged 18 yea... Read More

Gender:

ALL

Ages:

Between 18 years and 120 years

Trial Updated:

08/22/2025

Locations: National Institutes of Health Clinical Center, Bethesda, Maryland

Conditions: Multiple Myeloma, Newly Diagnosed Multiple Myeloma (NDMM), Relapsed and/or Refractory Multiple Myeloma (RRMM)

Learn More ›

Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer

NCT03412877

Recruiting

Background: A person s tumor is studied for mutations. When cells are found that can attack the mutation in a person s tumor, the genes from those cells are studied to find the parts that make the attack possible. White blood cells are then taken from the person s body, and the gene transfer occurs in a laboratory. A type of virus is used to transfer the genes that make those white blood cells able to attack the mutation in the tumor. The gene transfer therapy is the return of those white blood cells back to the person. Objective: To see if gene transfer therapy of white blood cells can shrink tumors. Eligibility: People with certain metastatic cancer for which standard treatments have not worked. Design: Participants may complete screening under another protocol. Screening includes: * Getting tumor cells from a previous procedure * Medical history * Physical exam * Scans * Blood, urine, heart, and lung tests The study has 8 stages: 1. Screening tests repeated over 1-2 weeks. Participants will have leukapheresis: Blood is removed by a needle in one arm. A machine removes white blood cells. The rest of the blood is returned by a needle in the other arm. 2. Care at home over approximately 12 weeks. 3. Stopping therapy for 4-6 weeks while their cells are changed in a lab. 4. Hospital stay approximately 3-4 weeks for treatment. An IV catheter will be placed in the chest to administer drugs. 5. Patients on Arm 2 of the study will receive the first dose of pembrolizumab while in the hospital. Three additional doses will be given after the cell infusion 3 weeks apart. 6. Receiving changed cells by catheter. Then getting a drug over 1-5 days to help the cells live longer. 7. Recover in the hospital for 1-2 weeks. Participants will get drugs and have blood and urine tests. 8. Participants will take an antibiotic and maybe an antiviral for at least 6 months after treatment. They will have repeat screening tests at visits every few months for the first year, every 6 months for the second year, then as determined. ... Read Less

Gender:

ALL

Ages:

Between 18 years and 72 years

Trial Updated:

08/22/2025

Locations: National Institutes of Health Clinical Center, Bethesda, Maryland

Conditions: Non-Small Cell Lung Cancer, Ovarian Cancer, Breast Cancer, Endocrine Tumors, Neuroendocrine Tumors, Gastrointestinal/Genitourinary Cancers, Multiple Myeloma

Learn More ›

Tissue Collection for Studies of Lymph Cancer

NCT01676805

Recruiting

Background: - Lab studies help researchers better understand cancer biology. This information may lead to new methods for diagnosing or treating cancer. To develop these studies, researchers want to collect samples from people with cancer or precancer conditions of the lymph system. These conditions include multiple myeloma, different types of lymphoma, and adult leukemia/lymphoma. The samples collected will include blood, urine, bone marrow, and tumor and skin tissue. Objectives: - To collec... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

08/22/2025

Locations: National Institutes of Health Clinical Center, Bethesda, Maryland +1 locations

Conditions: Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Lymphomatoid Granulomatosis, Leukemia-Lymphoma, Adult T-Cell

Learn More ›

Talquetamab & Lenalidomide as Post Stem Cell Transplant Maintenance in Multiple Myeloma

NCT06461988

Recruiting

Multiple myeloma (MM) is a heterogenous plasma cell malignancy characterized by clonal proliferation of plasma cells and organ damage. Autologous transplantation with high dose chemotherapy is the standard of care in frontline treatment of eligible patients with MM.

Gender:

ALL

Ages:

19 years and above

Trial Updated:

08/22/2025

Locations: Stanford University, Palo Alto, California

Conditions: Multiple Myeloma, Post Stem Cell Transplant

Learn More ›

A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma

NCT05827016

Recruiting

The purpose of this study is to compare the effectiveness of iberdomide maintenance to lenalidomide maintenance therapy after autologous stem cell transplantation (ASCT) in participants with newly diagnosed multiple myeloma (NDMM).

Gender:

ALL

Ages:

18 years and above

Trial Updated:

08/20/2025

Locations: Rocky Mountain Cancer Centers, Aurora, Colorado +284 locations

Rocky Mountain Cancer Centers, Aurora, Colorado

Mayo Clinic Florida, Jacksonville, Florida

Tampa General Hospital, Tampa, Florida

H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida

Cleveland Clinic, Weston, Florida

University Cancer Blood Ctr, Athens, Georgia

The Winship Cancer Institute of Emory University, Atlanta, Georgia

Augusta University - Georgia Cancer Center, Augusta, Georgia

The University of Chicago Medical Center - Duchossois Center for Advanced Medicine, Chicago, Illinois

University of Kansas Cancer Center - The Richard and Annette Bloch Cancer Care Pavilion, Westwood, Kansas

Maryland Oncology Hematology, PA- Clinton, Clinton, Maryland

UMass Memorial Medical Center, Worcester, Massachusetts

University of Michigan - Rogel Cancer Center, Ann Arbor, Michigan

Henry Ford Health System - The Henry Ford Cancer Institute (HFCI) - Detroit, Detroit, Michigan

Cancer & Hematology Centers of Western Michigan (CHCWM), Grand Rapids, Michigan

Mayo Clinic Cancer Center (MCCC) - Rochester, Rochester, Minnesota

Hattiesburg Clinic - Hematology & Oncology, Hattiesburg, Mississippi

Morristown Medical Center, Morristown, New Jersey

Local Institution - 0328, Brooklyn, New York

Perlmutter Cancer Center at NYU Langone Hematology Oncology Associates-Mineola, Mineola, New York

NYU Langone Health, New York, New York

Columbia University Medical Center - Herbert Irving Pavilion Location, New York, New York

Clinical Research Alliance, Westbury, New York

Local Institution - 0331, Charlotte, North Carolina

Novant Health Cancer Institute - Elizabeth, Charlotte, North Carolina

Duke University Hospital, Durham, North Carolina

Novant Health Cancer Institute Hematology - Forsyth, Winston-Salem, North Carolina

Local Institution - 0322, Winston-Salem, North Carolina

Oncology Hematology Care, Inc. - Cincinnati - Galbraith Rd, Cincinnati, Ohio

Cleveland Clinic - Fairview Hospital - Cancer Center (Moll Cancer Center), Cleveland, Ohio

Cleveland Clinic, Cleveland, Ohio

Midwest Oncology Associates - Kansas City, Kansas, Ohio

Cleveland Clinic - Hillcrest Hospital - Hillcrest Cancer Center, Mayfield Heights, Ohio

Local Institution - 0013, Toledo, Ohio

Wooster Milltown Specialty and Surgery Center, Wooster, Ohio

Willamette Valley Cancer Institute, Eugene, Oregon

Thomas Jefferson University Hospital, Philadelphia, Pennsylvania

Fox Chase Cancer Center - Jeanes Campus, Philadelphia, Pennsylvania

University of Pittsburgh - Hillman Cancer Center, Pittsburgh, Pennsylvania

West Cancer Center, Germantown, Tennessee

Tennessee Oncology, Nashville, Tennessee

Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas, Texas

UT Southwestern-Harold C. Simmons Cancer Center, Dallas, Texas

University of Texas MD Anderson Cancer Center, Houston, Texas

Local Institution - 0259, Mar del Plata, B

Hospital Universitario Austral, Pilar, B

Hospital Italiano de Buenos Aires, Ciudad Autonoma Buenos Aires, Caba

"Centro de Educación Médica e Investigaciones Clínicas ""Norberto Quirno""", Ciudad Autonoma Buenos Aires, Caba

Sanatorio Allende, Córdoba, Not set

Calvary Mater Newcastle, Waratah, New South Wales

Royal Adelaide Hospital, Adelaide, South Australia

Box Hill Hospital, Box Hill, Victoria

Monash Health, Clayton, Victoria

Ordensklinikum Linz Elisabethinen, Linz, Not set

Universitätsklinikum St. Pölten, St. Pölten, Not set

Medizinische Universitaet Wien - Universitaetsklinik fuer Augenheilkunde und Optometrie, Vienna, Not set

Hanusch-Krankenhaus, Vienna, Not set

Grand Hopital de Charleroi - Les Viviers, Charleroi, WHT

AZ Groeninge - Campus Kennedylaan, Kortrijk, Not set

Local Institution - 0245, Curitiba, PR

Local Institution - 0214, Niterói, RJ

Local Institution - 0082, Rio de Janeiro, RJ

Local Institution - 0081, Ribeirão Preto, SP

Local Institution - 0277, Sao Paulo, SP

Local Institution - 0194, São Paulo, SP

Local Institution - 0241, São Paulo, SP

Local Institution - 0190, Barretos, Not set

Local Institution - 0083, Porto Alegre, Not set

Local Institution - 0096, Rio de Janeiro, Not set

Local Institution - 0098, Salvador, Not set

Cross Cancer Institute, Edmonton, Alberta

The Ottawa Hospital - General Campus, Ottawa, Ontario

Jewish General Hospital, Montreal, Quebec

CHUQ - The Hôtel-Dieu de Québec, Quebec, Not set

Fundación Arturo López Pérez, Santiago, Not set

Local Institution - 0258, Temuco, Not set

Clinica Alemana - Vitacura, Vitacura, Not set

Anhui Provincial Hospital, Hefei, AH

Local Institution - 0326, Beijing, Beijing

The Fifth Medical Center of People's Liberation Army General Hospital, Beijing, Beijing

The First Affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing

Local Institution - 0321, Chongqing, CQ

Guangdong Provincial People's Hospital, Guangzhou Shi, Guangdong

Nanfang Hospital of Southern Medical University, Guangzhou, Guangdong

Shenzhen Second People's Hospital, Shenzhen, Guangdong

Henan Cancer Hospital, Zhengzhou City, Henan

The Third Xiangya Hospital of Central South University, Changsha, Hunan

Xiangya Hospital, Central South University, Changsha, Hunan

Nanjing Drum Tower Hospital - The Comprehensive Cancer Center, Nanjing, Jiangsu

The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu

Local Institution - 0263, Nanchang, Jiangxi

The First Hospital of Jilin University, Changchun, Jilin

Local Institution - 0094, Shenyang, Liaoning

The First Affiliated Hospital of the Air Force Medical University, Xi'an City, Shaanxi

The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi

Qilu Hospital of Shandong University, Jinan, Shandong

Local Institution - 0271, Shanghai, Shanghai

Local Institution - 0319, Shanghai, Shanghai

Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin

The First Affiliated Hospital - Zhejiang University School of Medicine, Hangzhou, Zhejiang

The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang

Beijing Chaoyang Hospital, Capital Medical University, Beijing, Not set

Peking University People's Hospital, Beijing, Not set

The Second Xiangya Hospital of Central South University, Changsha, Not set

Fujian Medical University Union Hospital, Fuzhou, Not set

Sun Yat-sen University Cancer Center, Guangzhou, Not set

Shandong Provincial Hospital, Jinan, Not set

Jiangsu Province Hospital, Nanjing, Not set

Qingdao Municipal Hospital, Qingdao, Not set

Ruijin Hospital Affiliated to The Shanghai Jiao Tong University Medical School, Shanghai, Not set

The First Affiliated Hospital of Soochow University, Suzhou Shi, Not set

Wenzhou Medical University - The First Affiliated Hospital, Wenzhou Shi, Not set

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan Shi, Not set

Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Not set

Local Institution - 0302, Monteria, COR

Instituto Nacional de Cancerología - Bogota, Bogota, Not set

Fundacion Centro de Tratamiento e Investigacion sobre Cancer Luis Carlos Sarmiento Angulo - CTIC, Bogota, Not set

Fundacion Oftalmologica de Santander - FOSCAL, Floridablanca, Not set

Hospital Pablo Tobon Uribe, Medellin, Not set

Sociedad de Oncologia y Hematologia del Cesar S.A.S, Valledupar, Not set

Fakultní Nemocnice Brno, Brno, Not set

Fakultní Nemocnice Olomouc, Olomouc, Not set

Všeobecná fakultní nemocnice v Praze, Prague 2, Not set

Fakultní nemocnice Královské Vinohrady, Prague, Not set

Odense Universitetshospital, Odense, Not set

Helsingin Yliopistollinen Sairaala (HUS) - Syopakeskus (Comprehensive Cancer Center), Helsinki, Not set

Kuopio University Hospital, Kuopio, Not set

CHU Hôpital Sud, Amiens Cedex 1, Not set

Institut d'Hématologie de Basse-Normandie (IHBN), Caen, Not set

CHU Hôpital Henri Mondor, Creteil, Not set

Centre Hospitalier Départemental Vendée - Hôpital de la Roche-sur-Yon, La Roche Sur Yon, Not set

Centre Hospitalier Régional Universitaire de Lille (CHRU) - Hôpital Claude Huriez, Lille, Not set

CHU Limoges - Hôpital Dupuytren, Limoges, Not set

Centre Hospitalier Universitaire de Nantes (CHU de Nantes) - Hotel-Dieu, Nantes, Not set

Hôpital Saint-Antoine, Paris, Not set

Hopital Pitie-Salpetriere, Paris, Not set

Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, Not set

Local Institution - 0314, Cottbus, BB

Charite-Universitaetsmedizin Berlin - Campus Benjamin Franklin (CBF), Berlin, BE

Universitätsklinikum Ulm, Ulm, BW

Local Institution - 0324, Augsburg, BY

Local Institution - 0312, Bayreuth, BY

Universitaetsklinikum Erlangen - Medizinische Klinik 5, Erlangen, BY

Local Institution - 0311, Muenchen, BY

Local Institution - 0315, Hamburg, HH

Local Institution - 0313, Hildesheim, NI

Local Institution - 0316, Chemnitz, SN

Universitätsklinikum Freiburg, Freiburg, Not set

Local Institution - 0310, Gottingen, Not set

Universitätsklinikum Hamburg-Eppendorf (UKE), Hamburg, Not set

St. Barbara-Klinik Hamm-Heessen GmbH, Hamm, Not set

Universitätsklinikum Jena, Jena, Not set

Local Institution - 0323, Marburg, Not set

Universitätsklinikum Tübingen, Tübingen, Not set

"General Hospital of Thessaloniki ""G. Papanikolaou""", Thessaloniki, B

University of Patras - Rio Regional University Hospital, Rio, G

Evangelismos General Hospital of Athens, Athina, I

Alexandra General Hospital of Athens, Athens, Not set

University of Thessaly- General University Hospital of Larissa, Larisa, Not set

Theageneio Cancer Hospital of Thessaloniki, Thessaloniki, Not set

Queen Mary Hospital, Hong Kong, HK

Debreceni Egyetem Klinikai Központ III. sz. Belgyógyászati Klinika, Debrecen, HB

Postgraduate Institute of Medical Education & Research (PGIMER), Chandigarh, CH

HCG Cancer Center - Kalinga Rao Road, Bangalore, Karnataka

Aster Medcity, Cochin, KL

Dr. Bafnas Star Superspecaility Clinic and Hospital, Kolhapur, MH

Alexis Multispeciality Hospital, Nagpur, MH

Deenanath Mangeshkar Hospital & Research Center, Pune, MH

Sahyadri Speciality Hospital Deccan Gymkhana, Pune, MH

Sparsh Hospitals & Critical Care, Bhubaneswar, Odisha

Tata Medical Center, Kolkata, WB

Local Institution - 0135, Navi Mumbai, Not set

Assuta Medical Center, Ashdod, Not set

Assaf Harofeh Medical Center, Beer Ya'Aqov, Not set

Hillel Yaffe Medical Center, Hadera, Not set

Rambam Medical Center, Haifa, Not set

Shaare Zedek Medical Center, Jerusalem, Not set

Hadassah University Medical Center, Jerusalem, Not set

Rabin Medical Center - Davidoff Center, Petah Tikva, Not set

The Chaim Sheba Medical Center, Ramat Gan, Not set

Local Institution - 0136, Tel Aviv-Yafo, Not set

Azienda Ospedaliero Universitaria Policlinico G. Rodolico San Marco - Ospedale San Marco, Catania, CT

Azienda Ospedaliero-Universitaria Careggi, Firenze, FI

Ospedale Policlinico San Martino, Genova, GE

Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milano, MI

ASST Grande Ospedale Metropolitano Niguarda, Milano, MI

Azienda Ospedaliero Universitaria Pisana - Ospedale Santa Chiara, Pisa, PI

Fondazione Policlinico Universitario Agostino Gemelli, Roma, RM

Azienda Ospedaliera Universitaria Citta della Salute e della Scienza di Torino - Ospedale Molinette, Torino, TO

"Azienda Ospedaliera Universitaria ""Federico II""", Naples, Not set

Fondazione IRCCS Policlinico San Matteo, Pavia, Not set

Policlinico Umberto I, Rome, Not set

National Hospital Organization (NHO) - Shibukawa Medical Center, Shibukawa-shi, Gunma

Shonan Kamakura General Hospital, Kamakura-Shi, Kanagawa

Kumamoto University Hospital, Kumamoto-shi, Kumamoto

Chiba University Hospital, Chiba-shi, Not set

Gifu Municipal Hospital, Gifu-Shi, Not set

Local Institution - 0133, Higashiibaraki-Gun, Not set

Hiroshima Red Cross Hospital & Atomic-Bomb Survivors Hospital, Hiroshima-shi, Not set

Tokai University Hospital, Isehara-shi, Not set

Local Institution - 0330, Itabashi-Ku, Not set

Kagoshima University Hospital, Kagoshima-Shi, Not set

Kanazawa University Hospital, Kanazawa-shi, Not set

Local Institution - 0134, Kobe-Shi, Not set

The Cancer Institute Hospital of Japanese Foundation for Cancer Research (JFCR), Koto-Ku, Not set

Gunma University Hospital, Maebashi-Shi, Not set

The Jikei University Hospital, Minato-Ku, Not set

The Japanese Red Cross Nagasaki Genbaku Hospital, Nagasaki-Shi, Not set

Nagoya City University Hospital, Nagoya-Shi, Not set

Local Institution - 0329, Nerima-Ku, Not set

Kindai University Hospital, Osakasayama-Shi, Not set

Jichi Medical University Saitama Medical Center, Saitama-shi, Not set

Sapporo Hokuyu Hospital, Sapporo-shi, Not set

National Hospital Organization Sendai Medical Center, Sendai-shi, Not set

Japanese Red Cross Medical Center, Shibuya-ku, Not set

Shizuoka Cancer Center, Sunto-gun, Not set

Pusan National University Hospital, Busan, Not set

National Cancer Center, Goyang-si, Not set

Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Not set

Yonsei University Health System, Severance Hospital, Seoul, Not set

Samsung Medical Center, Seoul, Not set

Ulsan University Hospital (UUH), Ulsan, Not set

Local Institution - 0127, Mexico, CMX

Local Institution - 0146, Toluca De Lerdo, MEX

Local Institution - 0283, Monterrey, NL

Local Institution - 0107, Mexico city, Not set

VU University Medical Center, Amsterdam, NH

Local Institution - 0325, Almere, Not set

Albert Schweitzer Hospital - Locatie Dordwijk, Dordrecht, Not set

Szpital Uniwersytecki Nr. 2 im Dr. Jana Biziela w Bydgoszczy, Bydgoszcz, KP

Wojewódzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im. M. Kopernika w Łodzi, Lodz, LD

Uniwersyteckie Centrum Kliniczne, Gdansk, PM

Local Institution - 0327, Bydgoszcz, Not set

Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology Gliwice Branch, Gliwice, Not set

Pratia Onkologia Katowice, Katowice, Not set

Office of Dr n. Med. Wojciech Legiec, Lublin, Not set

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy, Warsaw, Not set

Unidade Local de Saude Braga, Braga, Not set

Unidade Local de Saude de Coimbra, EPE - Hospitais da Universidade de Coimbra, Coimbra, Not set

Instituto Português Oncologia do Porto Francisco Gentil, EPE, Porto, Not set

Institutul Clinic Fundeni, Bucureşti, B

Spitalul Clinic Municipal Filantropia Craiova, Craiova, Dolj

Institutul Regional de Oncologie Iași, Iasi, IS

"Institutul Oncologic ""Prof. Dr. Ion Chiricuţă"" Cluj Napoca", Cluj-Napoca, Jud. Cluj

"Institutul Oncologic ""Prof. Dr. Ion Chiricuţă"" Cluj Napoca", Cluj-Napoca, Not set

National University Hospital (S) Pte Ltd, Singapore, Not set

Singapore General Hospital, Singapore, Not set

Hospital Universitario Central de Asturias, Oviedo, Asturias

Hospital Clínic de Barcelona, Barcelona, B

Hospital San Pedro de Alcántara, Cáceres, CC

Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Las Palmas

Hospital Universitario Virgen Arrixaca, Murcia, MU

Hospital Universitari i Politècnic La Fe, Valencia, VC

Hospital Universitari Germans Trias i Pujol, Badalona, Not set

Clínica Universidad de Navarra -Madrid, Madrid, Not set

Hospital Universitari Son Espases, Palma de Mallorca, Not set

Clínica Universidad de Navarra, Pamplona, Not set

Local Institution - 0171, Luleå, BD

Södra Älvsborgs Sjukhus, Borås, Not set

Vastra Goetalandsregionen - Uddevalla Sjukhus (US), Uddevalla, Not set

Local Institution - 0168, Aarau 1, Not set

Chang Gung Medical Foundation - Kaohsiung Branch, Kao-Hsiung, Not set

E-DA Cancer Hospital, Kaohsiung, Not set

Far Eastern Memorial Hospital, New Taipei City, Not set

National Cheng Kung University Hospital, Tainan, Not set

National Taiwan University Hospital, Taipei, Not set

Chang Gung Memorial Hospital, Taoyuan, Not set

Ankara Bilkent City Hospital, Ankara, Not set

Liv Hospital Ankara, Cankaya, Not set

Trakya Üniversitesi Tıp Fakültesi, Edirne, Not set

Local Institution - 0068, Istanbul, Not set

T.C. Istanbul Bilim Universitesi - lstanbul Florence Nightingale Hastanesi, Istanbul, Not set

Ege Universitesi Tip Fakultesi Hastanesi (Ege University Medical Faculty Hospital), Izmir, Not set

Local Institution - 0073, Izmir, Not set

Erciyes Üniversitesi Tıp Fakültesi, Kayseri, Not set

Dr. Abdurrahman Yurtaslan Ankara Onkoloji Eğitim ve Araştırma Hastanesi, Yenimahalle, Not set

NHS Grampian - Aberdeen Royal Infirmary, Aberdeen, ABD

GenesisCare -Windosr, Windsor, Berkshire

University Hospitals of Derby and Burton NHS Foundation Trust - Royal Derby Hospital, Derby, DBY

University Hospitals Dorset NHS Foundation Trust (UHD) - Royal Bournemouth Hospital (RBH), Bournemouth, DOR

Portsmouth Hospitals NHS Trust - Queen Alexandra Hospital, Portsmouth, HAM

University Hospitals of North Midlands NHS Trust (UHNM) - Royal Stoke University Hospital, Stoke-on-Trent, Staffordshire

NHS Lothian - Western General Hospital, Edinburgh, Not set

Barts Health NHS Trust - St Bartholomew's Hospital, London, Not set

GenesisCare-Oxford, Oxford, Not set

Conditions: Multiple Myeloma

Learn More ›

Combination Therapy (Mirdametinib and Sirolimus) for RAS Mutated Relapsed Refractory Multiple Myeloma

NCT06876142

Recruiting

Background: Multiple myeloma (MM) is a type of blood cancer that affects a person s immunity. MM returns after treatment (relapse) in almost all people; MM may also not respond to initial treatment (refractory). Many people with relapsed refractory MM (RRMM) also have changes in their KRAS and NRAS genes. Researchers want to try a new drug treatment that targets cancer with these changed genes. Objective: To test 2 drugs (mirdametinib and sirolimus) in people with RRMM. Eligibility: People... Read More

Gender:

ALL

Ages:

Between 18 years and 120 years

Trial Updated:

08/20/2025

Locations: National Institutes of Health Clinical Center, Bethesda, Maryland

Conditions: Multiple Myeloma, Relapsed and/or Refractory Multiple Myeloma (RRMM)

Learn More ›

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

NCT05552222

Recruiting

The purpose of this study is to compare the efficacy of teclistamab in combination with daratumumab and lenalidomide (Tec-DR) and talquetamab in combination with daratumumab and lenalidomide (Tal-DR) versus daratumumab, lenalidomide, dexamethasone (DRd).

Gender:

ALL

Ages:

18 years and above

Trial Updated:

08/19/2025

Locations: UCSF Fresno, Clovis, California +228 locations

UCSF Fresno, Clovis, California

City of Hope Cancer Center, Duarte, California

City of Hope Orange County Lennar Foundation Cancer Center, Irvine, California

University of Connecticut, Farmington, Connecticut

Yale New Haven Hospital, New Haven, Connecticut

ChristianaCare Helen F Graham Cancer Center and Research Institute, Newark, Delaware

Cleveland Clinic Florida, Weston, Florida

University Of Illinois Medical Center, Chicago, Illinois

University of Iowa Health Care, Waukee, Iowa

Norton Cancer Institute, Louisville, Kentucky

LSUHSC Shreveport Feist-Weiller Cancer Center, Shreveport, Louisiana

Johns Hopkins University School of Medicine JHUSOM, Baltimore, Maryland

Cancer And Hematology Centers of Western Michigan PC, Grand Rapids, Michigan

Nebraska Cancer Specialists, Omaha, Nebraska

University of Nebraska Medical Center, Omaha, Nebraska

Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire

Astera Cancer Care, East Brunswick, New Jersey

Christus St. Vincent Regional Cancer Center, Santa Fe, New Mexico

Hematology-Oncology Associates of CNY, East Syracuse, New York

Northwell Health Cancer Institute, Lake Success, New York

NYU Langone Hospital Long Island, Mineola, New York

Perlmutter Cancer Center at NYU Langone Health, New York, New York

Memorial Sloan Kettering Cancer Center, New York, New York

Durham VAMC, Durham, North Carolina

University of Cincinnati, Cincinnati, Ohio

University Hospitals Cleveland Medical Center, Cleveland, Ohio

OhioHealth, Columbus, Ohio

Allegheny Health Network, Pittsburgh, Pennsylvania

Joe Arrington Cancer Research Treatment Center, Lubbock, Texas

Utah Cancer Specialists, Salt Lake City, Utah

NorthWest Medical Specialties, PLLC, Tacoma, Washington

Royal Prince Alfred Hospital, Camperdown, Not set

Barwon Health - University Hospital Geelong, Geelong, Not set

Liverpool Hospital, Liverpool, Not set

Sir Charles Gairdner Hospital, Nedlands, Not set

Calvary Mater Newcastle Hospital, New South Wales, Not set

Wollongong Hospital, Wollongong, Not set

Princess Alexandra Hospital, Woolloongabba, Not set

Ordensklinikum Linz GmbH Elisabethinen, Linz, Not set

SCRI CCCIT gem GmbH, Salzburg, Not set

Medical University Vienna, Vienna, Not set

Hanusch Krankenhaus, Wien, Not set

Institut Jules Bordet, Anderlecht, Not set

ZAS Cadix, Antwerpen, Not set

Ghent University Hospital, Gent, Not set

Jolimont, Haine Saint Paul La Louviere, Not set

Az Groeninge, Kortrijk, Not set

Universitair Ziekenhuis Leuven, Leuven, Not set

GZA Ziekenhuizen- Campus St Augustinus, Wilrijk, Not set

Fundacao Pio XII, Barretos, Not set

Santa Casa de Misericordia de Belo Horizonte, Belo Horizonte, Not set

Liga Paranaense de Combate ao Cancer, Curitiba, Not set

Instituto Do Cancer Do Ceara, Fortaleza, Not set

Liga Norte Riograndense Contra O Cancer, Natal, Not set

Complexo Hospitalar de Niteroi, Niteroi, Not set

Hospital De Clinicas De Porto Alegre, Porto Alegre, Not set

Hospital Das Clinicas Da Faculdade De Medicina De RPUSP HCRP, Ribeirao Preto, Not set

Hospital Sao Rafael, Salvador, Not set

Hospital Nove de Julho, Sao Paulo, Not set

Clinica Medica Sao Germano S/S LTDA, Sao Paulo, Not set

Hospital Das Clinicas Da Faculdade De Medicina Da USP, Sao Paulo, Not set

Arthur J E Child Comprehensive Cancer Centre, Calgary, Alberta

Cross Cancer Institute, Edmonton, Alberta

British Columbia Cancer Agency, Vancouver, British Columbia

CHU de Quebec L Hotel Dieu de Quebec, Quebec, Not set

Peking Union Medical College Hospital, Beijing, Not set

Peking University First Hospital, Beijing, Not set

Beijing Tongren Hospital CMU, Beijing, Not set

Changzhou No 2 Peoples Hospital, Chang Zhou, Not set

The First Hospital of Jilin University, Changchun, Not set

The Second Xiangya Hospital of Central South Hospital, Changsha, Not set

Beijing Chaoyang Hospital, Chaoyang District, Not set

Sichuan Provincial Peoples Hospital, Chengdu, Not set

Chongqing University Cancer Hospital, Chongqing, Not set

Fujian Meidical University Union Hospital, Fu Zhou, Not set

Nanfang Hospital, Guangzhou, Not set

Sun Yat -Sen University Cancer Center, Guangzhou, Not set

The Second Affiliated Hospital of Zhejiang University, Hang Zhou, Not set

No.1 Affiliated Hospital, Medical College of Zhejiang University, Hangzhou, Not set

Harbin medical university cancer hospital, Harbin, Not set

Qilu Hospital of Shandong University, Jinan, Not set

Zhongda Hospital Southeast University, Nan Jing, Not set

The First Affiliated Hospital of Guangxi Medical University, Nan Ning Shi, Not set

The First Affliated Hospital Of Nanchang University, Nanchang, Not set

Nanjing Drum Tower Hospital, Nanjing, Not set

Ruijin Hospital Shanghai Jiao Tong University, Shanghai, Not set

Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, Not set

Shanghai Fourth People s Hospital, Shanghai, Not set

Peking University Shenzhen Hospital, Shen Zhen Shi, Not set

Shengjing Hospital Of China Medical University, Shenyang, Not set

Institute of Hematology and Blood Diseases Hospital, Tian Jin, Not set

Tianjin Medical University Cancer Institute and Hospital, Tianjin, Not set

The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Not set

Wuhan Tongji Hospital Tongji Medical College, WuHan, Not set

The Second Affiliated Hospital of Xi'an Jiaotong University, Xi' An, Not set

The first affiliated hospital of xiamen university, Xiamen, Not set

Henan Cancer Hospital, Zhengzhou, Not set

Fakultni nemocnice Brno, Brno - Bohunice, Not set

Fakultni nemocnice Hradec Kralove, Hradec Kralove, Not set

Fakultni nemocnice Olomouc, Olomouc, Not set

Fakultni Nemocnice Ostrava, Ostrava, Not set

Fakultni nemocnice Plzen, Plzen, Not set

VFN v Praze, Praha, Not set

Aalborg University Hospital, Aalborg, Not set

Regionshospitalet Godstrup, Herning, Not set

Zealand University Hospital, Roskilde, Not set

Vejle Sygehus, Vejle, Not set

APHP - Hopital Henri Mondor, Creteil, Not set

Hopital Claude Huriez, Lille, Not set

CHU Nantes, Nantes, Not set

CHU Hopital Saint Antoine, PARIS cedex 12, Not set

CHU de Bordeaux - Hospital Haut-Leveque, Pessac cedex, Not set

CHU Lyon Sud, Pierre-Benite, Not set

CHU Poitiers - Hopital la Miletrie, Poitiers, Not set

CHU de Rennes - Hopital Pontchaillou, Rennes, Not set

Institut de Cancerologie Strasbourg Europe ICANS, Strasbourg, Not set

Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, Not set

Helios Kliniken Berlin Buch Gmbh, Berlin, Not set

Med. Universitatsklinik Essen, Essen, Not set

Universitaetsklinikum Halle Saale, Halle (Saale), Not set

Universitaetsklinik Hamburg-Eppendorf, Hamburg, Not set

Klinikum Nuernberg Nord, Nuernberg, Not set

Universitaetsklinikum Tuebingen der Eberhard-Karls-Universitaet, Abteilung fuer Innere Medizin II,, Tübingen, Not set

Universitaetsklinikum Wuerzburg, Wurzburg, Not set

Alexandra General Hospital of Athens, Athens Attica, Not set

G Papanikolaou Hospital of Thessaloniki, Thessalonikis, Not set

Anticancer Hospital of Thessaloniki Theageneio, Thessaloniki, Not set

Rambam Medical Center, Haifa, Not set

Shaare Zedek Medical Center, Jerusalem, Not set

Rabin, Petah Tikva, Not set

Sheba Medical Center, Ramat Gan, Not set

Tel Aviv Sourasky Medical Center, Tel Aviv Yafo, Not set

ASST Papa Giovanni XXIII Bergamo, Bergamo, Not set

A O U Sant Orsola Malpighi, Bologna, Not set

Careggi University Hospital, Firenze, Not set

Ospedale San Raffaele, Milan, Not set

Azienda Ospedaliera di Rilievo Nazionale A Cardarelli, Naples, Not set

IRCCS Policlinico San Matteo, Università degli studi di Pavi, Pavia, Not set

Universita Degli Studi di Roma Tor Vergata, Roma, Not set

Istituto Clinico Humanitas, Rozzano, Not set

Azienda Ospedaliera Universitaria Citta della Salute e della Scienza di Torino, Torino, Not set

Juntendo University Hospital, Bunkyo Ku, Not set

Chiba Cancer Center, Chiba, Not set

Kameda Medical Center, Chiba, Not set

National Hospital Organization Mito Medical Center, Higashiibaraki-gun, Not set

Kansai Medical University Hospital, Hirakata, Not set

Hyogo Medical University Hospital, Hyôgo, Not set

Saitama Medical University Hospital, Iruma-gun, Not set

Tokai University Hospital, Kanagawa, Not set

Kanazawa University Hospital, Kanazawa, Not set

Kumamoto University Hospital, Kumamoto-shi, Not set

Matsuyama Red Cross Hospital, Matsuyama-City, Not set

National Hospital Organization Nagasaki Medical Center, Nagasaki, Not set

National Hospital Organization Okayama Medical Center, Okayama, Not set

Osaka Metropolitan University Hospital, Osaka, Not set

National Hospital Organization Hokkaido Cancer Center, Sapporo, Not set

National Hospital Organization Shibukawa Medical Center, Shibukawa, Not set

Japanese Red Cross Medical Center, Shibuya-ku, Not set

Shizuoka Cancer Center, Sunto Gun, Not set

Fujita Health University Hospital, Toyoake, Not set

Yamagata University Hospital, Yamagata, Not set

Yamanashi Prefectural Central Hospital, Yamanashi, Not set

Dong-A University Hospital, Busan, Not set

Pusan National University Hospital, Busan, Not set

Kyungpook National University Hospital, Daegu, Not set

National Cancer Center, Goyang si, Not set

Chonnam National University Hwasun Hospital, Hwasun, Not set

Gachon University Gil Medical Center, Incheon, Not set

Seoul National University Hospital, Seoul, Not set

Severance Hospital Yonsei University Health System, Seoul, Not set

Asan Medical Center, Seoul, Not set

Samsung Medical Center, Seoul, Not set

The Catholic University of Korea Seoul St Mary s Hospital, Seoul, Not set

VUMC Amsterdam, Amsterdam, Not set

Gelre Ziekenhuis, Apeldoorn, Not set

Reinier de Graaf Gasthuis, Delft, Not set

St. Antonius Ziekenhuis Nieuwegein, Nieuwegein, Not set

Zuyderland Medical Center, Sittard-Geleen, Not set

Oslo University Hospital HF Ulleval sykehus, Oslo, Not set

St. Olavs Hospital, Trondheim, Not set

Wojewodzki Szpital Kliniczny w Bialej Podlaskiej, Biala Podlaska, Not set

Szpital Specjalistyczny w Brzozowie Podkarpacki Osrodek Onkologiczny im Ks B Markiewicza, Brzozow, Not set

Szpital Uniwersytecki nr 2 im. Jana Biziela w Bydgoszczy, Bydgoszcz, Not set

Pratia Onkologia Katowice, Katowice, Not set

Swietokrzyskie Centrum Onkologii SPZOZ w Kielcach, Kielce, Not set

Wojewodzkie Wielospecjalistyczne Centrum Onkologii i Traumatologii im M Kopernika w Lodzi, Lodz, Not set

Centrum Onkologii Ziemi Lubelskiej im sw Jana z Dukli, Lublin, Not set

Uniwersytecki Szpital Kliniczny w Poznaniu, Poznan, Not set

Szpital Uniwersytecki im Karola Marcinkowskiego w Zielonej Gorze, Zielona Gora, Not set

Uls Braga - Hosp. Braga, Braga, Not set

Champalimaud Foundation Champalimaud Centre, Lisbon, Not set

Instituto Portugues de Oncologia, Porto, Not set

Uls Hosp Sao Joao, Porto, Not set

Hosp. Univ. Germans Trias I Pujol, Badalona, Not set

Hosp. de La Santa Creu I Sant Pau, Barcelona, Not set

Hosp Univ Vall D Hebron, Barcelona, Not set

Hosp. Univ. Virgen de Las Nieves, Granada, Not set

Hosp. de Jerez de La Frontera, Jerez de la Frontera, Not set

Hosp. Univ. 12 de Octubre, Madrid, Not set

Hosp. Univ. La Paz, Madrid, Not set

Hosp Univ Hm Sanchinarro, Madrid, Not set

Hosp. Univ. Son Espases, Palma de Mallorca, Not set

Hosp. Quiron Madrid Pozuelo, Pozuelo de Alarcon, Not set

Hosp Clinico Univ de Salamanca, Salamanca, Not set

Hosp. Mutua Terrassa, Terrassa, Not set

Hosp. Clinico Univ. de Valencia, Valencia, Not set

Falu Lasarett, Falun, Not set

Skanes universitetssjukhus, Lund, Not set

Karolinska University Hospital Huddinge, Stockholm, Not set

Universitetssjukhuset Orebro, Örebro, Not set

Inselspital Universitatsspital Bern, Bern, Not set

Kantonsspital St Gallen, St. Gallen, Not set

Dr Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Not set

Ankara University Medical Faculty, Ankara, Not set

Liv Hospital Ankara, Ankara, Not set

Memorial Antalya Hospital, Antalya, Not set

Pamukkale University Medical Faculty, Denizli, Not set

Medipol University Hospital, Istanbul, Not set

Dokuz Eylul University Medical Faculty, Izmir, Not set

Ondokuz Mayis University, Samsun, Not set

University Hospitals Birmingham NHS Foundation Trust, Birmingham, Not set

Blackpool Victoria Hospital, Blackpool, Not set

University Hospitals Bristol and Weston, Bristol, Not set

Addenbrooke's Hospital, Cambridge, Not set

Kent and Canterbury Hospital, Canterbury, Not set

Western General Hospital, Edinburgh, Not set

University College London Hospitals, London, Not set

Imperial College Healthcare, London, Not set

New Cross Hospital, Wolverhampton, Not set

Conditions: Multiple Myeloma

Learn More ›

Phase I/II Open Label Study of Belumosudil Mesylate Alone, and in Combination With Dexamethasone, in Patients With Relapsed/Refractory Multiple Myeloma

NCT06105554

Recruiting

Phase 1 is to find the recommended dose of belumosudil mesylate that can be given to patients with relapsed/refractory MM. Phase 2 is to learn if the dose of belumosudil mesylate found in Phase 1 can help to control the disease.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

08/19/2025

Locations: M D Anderson Cancer Center, Houston, Texas

Conditions: Multiple Myeloma

Learn More ›

A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)

NCT05640843

Recruiting

The researchers are doing this study to look at how butyrate levels change in participants' stool after they are on a- plant-based diet for at least 12 weeks. All participants will have monoclonal gammopathy of undetermined significance (MGUS) or smoldering multiple myeloma (SMM). We will compare how the plant-based diet, omega-3 fatty acid and curcumin supplements, and placebo (an inactive substance that looks like the study supplements) affect butyrate levels in participants' stool.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

08/19/2025

Locations: Emory University (Data Collection Only), Atlanta, Georgia +7 locations

Conditions: Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance

Learn More ›

At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer

NCT05969860

Recruiting

This clinical trial studies the effect of cancer directed therapy given at-home versus in the clinic for patients with cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). Currently most drug-related cancer care is conducted in infusion centers or specialty hospitals, where patients spend many hours a day isolated from family, friends, and familiar surroundings. This separation adds to the physical, emotional, social, and... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

08/18/2025

Locations: Mayo Clinic in Florida, Jacksonville, Florida +1 locations

Conditions: Advanced Malignant Solid Neoplasm, Advanced Anal Carcinoma, Advanced Biliary Tract Carcinoma, Advanced Bladder Carcinoma, Advanced Breast Carcinoma, Advanced Carcinoid Tumor, Advanced Cervical Carcinoma, Advanced Colorectal Carcinoma, Advanced Gastric Carcinoma, Advanced Glioblastoma, Advanced Head and Neck Carcinoma, Advanced HER2 Positive Breast Carcinoma, Advanced Lung Carcinoma, Advanced Lung Small Cell Carcinoma, Advanced Malignant Germ Cell Tumor, Advanced Neuroendocrine Carcinoma, Advanced Ovarian Carcinoma, Advanced Pancreatic Carcinoma, Advanced Prostate Carcinoma, Advanced Prostate Small Cell Neuroendocrine Carcinoma, Hematopoietic and Lymphoid System Neoplasm, Multiple Myeloma, Myelodysplastic Syndrome, Advanced Basal Cell Carcinoma, Advanced Cholangiocarcinoma, Advanced Endometrial Carcinoma, Advanced Esophageal Carcinoma, Advanced Fallopian Tube Carcinoma, Advanced Hepatocellular Carcinoma, Advanced Liver Carcinoma, Advanced Lymphoma, Advanced Malignant Testicular Neoplasm, Advanced Melanoma, Advanced Merkel Cell Carcinoma, Advanced Penile Carcinoma, Advanced Primary Malignant Central Nervous System Neoplasm, Advanced Renal Cell Carcinoma, Advanced Sarcoma, Advanced Skin Squamous Cell Carcinoma, Advanced Urethral Carcinoma, Advanced Vaginal Carcinoma, Advanced Vulvar Carcinoma, Appendix Carcinoma

Learn More ›

Sequential Therapy in Multiple Myeloma Guided by MRD Assessments

NCT05231629

Recruiting

This research study will determine the proportion of patients with lowest minimal residual disease (MRD) response obtainable after receiving 6 cycles of study treatment. Minimal residual disease is multiple myeloma cells below the level of 1 cancer cell out of 100,000 in the bone marrow. For patients who become MRD "negative" (i.e. less than 1 cancer cell out of 100,000) at the end of 6 cycles of therapy, this study will study if that good response can be maintained with 3 additional cycles of... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

08/18/2025

Locations: University of Alabama at Birmingham, Birmingham, Alabama +9 locations

Conditions: Multiple Myeloma

Learn More ›